semaglutide huberman Andrew on Retatrutide: What He Said and What the Data Shows Semaglutide GLP-1 Receptor Agonist Research

Muscle loss is a real risk, but it can be offset with strength training and adequate protein intake

For example, back pain and musculoskeletal discomfort appear in certain GLP-1 agonist SmPCs as uncommon or common adverse reactions

TB500 is not a muscle-building steroid or cosmetic enhancer its a therapeutic recovery compound with targeted applications for injury repair, tissue regeneration, and inflammation modulation

It is especially useful for: Speeding up soft tissue recovery Increasing flexibility Reducing muscle tightness Like BPC-157, TB-500 is not FDA-approved and falls under Category 2, meaning it is for research use only and not governed by the same safety standards as FDA-regulated medications